In progress
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Work plan
Work plan
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Chemicals
- Paraquat
1. Nomination
1. Nomination
Phase status
CompletedParaquat active constituents, chemical products and labels were nominated for review in response to an invitation to the public by the APVMA (then the NRA) on 1 November 1994. Eighty of the nominated chemicals, including paraquat, were included in the priority candidate review list published in the Gazette on 2 May 1995.
2. Prioritisation
2. Prioritisation
Phase status
Completed
3. Scoping and work plan
3. Scoping and work plan
Phase status
CompletedThe scope of the review includes reconsideration of paraquat active constituents, chemical products and labels through assessments related to residues, environment and human health, including work health and safety.
The work plan was first published on 1 July 2015.
4. Notice of reconsideration
4. Notice of reconsideration
Phase status
CompletedThe s 32 notice of reconsideration for active constituents, chemical products and labels for paraquat was published in the Gazette on 2 December 1997. The deadline for submissions was 31 May 1998 and was extended until 30 September 1998 as published in the Gazette on 7 April 1998.
The s 32 notice of reconsideration was given to holders and chemical coordinators of the states and territories upon commencement of the review on 27 October 1997.
Additional s 32 notices were sent to holders on 4 March 1998 to request technical data.
Additional s 32 notices were sent to holders on 1 July 2015 to include all approved actives and registered products in the review.
Additional s 32 notices were sent to holders on 10 May 2016 to include all approved actives and registered products in the review.
Additional s 32 notices were sent to holders on 16 August 2017 to include all approved actives and registered products in the review.
An additional s 33 was sent to a holder on 2 September 2021 to request additional data.
5. Assessment
5. Assessment
Phase status
In ProgressWhen the component risk assessments have been completed, the proposed regulatory decisions will be drafted.
6. Proposed regulatory decision
6. Proposed regulatory decision
Phase status
ForecastedPublication of the proposed regulatory decision is expected in June 2023.
7. Consultation
7. Consultation
Phase status
ForecastedThe legislated timeframe for consultation following publication of the proposed regulatory decision is 3 months.
8. Final regulatory decision
8. Final regulatory decision
Phase status
ForecastedFollowing the close of the public consultation period on the proposed regulatory decision, and consideration of submissions received, the final regulatory decision will be published.
Publication of the final regulatory decision is expected in October 2023.
9. Implementation
9. Implementation
Phase status
ForecastedThe implementation period will begin on the date the final regulatory decision is made.
Publication archive
Publication Archive
| Type | Title | Publication date |
|---|---|---|
| Report | Paraquat toxicology report – summary | 26 October 2016 |
| Report | Paraquat toxicology report – supplement I toxicology | 26 October 2016 |
| Report | Paraquat toxicology report – supplement II neurotoxicology | 26 October 2016 |